BioOrbit
BioOrbit is a London-based in-space manufacturing company, founded in 2023, that uses microgravity to crystallise protein-based biologic drugs at scale. Its autonomous BOX hardware — a compact, microwave-sized manufacturing unit designed to operate in low-Earth orbit — grows highly ordered crystalline forms of therapeutic proteins that reduce viscosity, enabling treatments normally given intravenously (including cancer therapies) to be reformulated as subcutaneous, self-injectable products. Co-founded by Dr Katie King and Dr Leonor Teles, BioOrbit raised the world's largest seed round for in-space manufacturing (~£9.8M / $13.2M) co-led by LocalGlobe and Breega with Seedcamp, Auxxo, Type One, 7percent and angels, and is supported by the UK Space Agency, ESA BIC and ESA BSGN. It was added to the API Evangelist network as a Seedcamp portfolio company; it publishes no public API or developer surface.
BioOrbit is profiled on the APIs.io network. Tagged areas include Company, Space, Biotechnology, Pharmaceuticals, and Manufacturing.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 3
The organization behind the API